OSSIX whole portfolio video

The OSSIX® product line is a regenerative product portfolio designed to
promote the neoformation of vital soft and hard tissue without leaving
remnants. The OSSIX® products are based on type-1 and type-3 collagen and demonstrate enhanced biodurability properties due to the proprietary
GLYMATRIX® technology. GLYMATRIX® technology is similar to the process
of cross-linking in the human body, in which naturally occurring non-toxic
sugar is used as a crosslinking agent.

Reference

1. Neiva R (2022). Evolution of Biomaterials in Implant Dentistry Leads to Enhanced Tissue Quality, in COMPENDIUM July/August 2022.

2. Casarez-Quintana A, et al (2022). Comparing the histological assessment following ridge preservation using a composite bovine-derived xenograft versus an alloplast hydroxyapatite-sugar cross-linked collagen matrix. Journal of periodontology, 2022;1–10.

3. Data on file

4. Sell D. R. and Monnier V. M. "Structure Elucidation of a Senescence Cross-link from Human Extracellular Matrix". J. Bio. Chem. 1989: 264(36); 21597-21602.

5. Klinger A et al (2010). In vivo degradation of collagen barrier membranes exposed to the oral cavity. Clin Oral Implants Res, Aug;21(8):873-6.